Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2002
Report date:
2002

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Qualifier:
according to guideline
Guideline:
EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
1-(2-(4-(chloromethyl)phenoxy)ethyl)azepane hydrochloride
Cas Number:
223251-25-0
Molecular formula:
C15H23Cl2NO
IUPAC Name:
1-(2-(4-(chloromethyl)phenoxy)ethyl)azepane hydrochloride
Test material form:
solid: particulate/powder

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
The test item was suspended in vehicle (bi-distilled water) at a concentration of 0.02 g/ml and administered at a volume of 10 ml/kg.
Doses:
2000 and 200 mg/kg b.w.
No. of animals per sex per dose:
3 female rats were treated at 2000 mg/kg b.w.
3 male or 3 female rats were treated at 200 mg/kg b.w.
Details on study design:
The animals were examined for clinical signs daily during the acclimatization period, four times during test day 1 and once daily during test days 2-15. Mortality/viability was recorded daily during the acclimatization period and together with clinical signs at the same time intervals on test day 1 and twice daily on test days 2-15. Body weight were recorded on day 1 (prior to administration) and on days 8 and 15. All animals were necropsied and examined macroscopically.

Results and discussion

Effect levelsopen allclose all
Sex:
female
Dose descriptor:
LD50
Effect level:
> 200 - < 2 000 mg/kg bw
Based on:
test mat.
Sex:
male
Dose descriptor:
LD50
Effect level:
> 200 mg/kg bw
Based on:
test mat.
Mortality:
The females at 2000 mg/kg died one hour after the test item application. No mortality at 200 mg/kg was observed.
Clinical signs:
dyspnea, slight sedation and lateral recumbency was observed in female no.8 on test day 1. No clinical signs were noted in all other animals during the course of the study.
Body weight:
The body weight was within the common range.
Gross pathology:
No macroscopic findings were observed at necropsy.

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
The median lethal dose of the substance after single oral administration to rats, observed over a period of 14 days is 200 < LD50 < 2000 mg/kg b.w.